Targeting the mTOR pathway using novel ATP‑competitive inhibitors, Torin1, Torin2 and XL388, in the treatment of glioblastoma
Anubhav G. Amin(Westchester Medical Center), Meena Jhanwar‐Uniyal(Westchester Medical Center)
Cited by 29
Related Papers
Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid
|Oncology Reports|2013|49
Molecular Sequence of Events and Signaling Pathways in Cerebral Metastases
|Anticancer Research|2018|12